Antisense oligodeoxynucleotides as clinical therapeutic agents.

Cancer Invest

Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA.

Published: April 1996

Download full-text PDF

Source
http://dx.doi.org/10.3109/07357909609018436DOI Listing

Publication Analysis

Top Keywords

antisense oligodeoxynucleotides
4
oligodeoxynucleotides clinical
4
clinical therapeutic
4
therapeutic agents
4
antisense
1
clinical
1
therapeutic
1
agents
1

Similar Publications

Targeted Cx43 therapeutics reduce NLRP3 inflammasome activation in rat burn injury.

Burns

December 2024

Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Clinical Sciences Building, 11, Mandalay Road, 308232, Singapore; Skin Research Institute Singapore, Level 17, Clinical Sciences Building, 11, Mandalay Road, 308232,  Singapore; National Skin Centre Singapore, 1 Mandalay Rd, 308205, Singapore. Electronic address:

Burns are dynamic injuries characterized by an initial zone of necrosis that progresses to compromise surrounding tissue. Acute inflammation and cell death are two main factors contributing to burn progression. These processes are modulated by Connexin43 (Cx43) hemichannels and gap junctions in burns and chronic wounds.

View Article and Find Full Text PDF

Inflammatory mediators tumor necrosis factor (TNF) and interleukin 1 beta (IL1β), primarily derived from hepatic macrophages in the liver, play a crucial role in the progression of nonalcoholic steatohepatitis (NASH). Meanwhile, intravenously injected exosomes are mainly distributed in the liver and predominantly taken up by hepatic macrophage. Herein, we aimed to evaluate the feasibility of targeted inhibition of TNF and IL1β expression in hepatic macrophages via exosomes as a potential therapeutic strategy for NASH.

View Article and Find Full Text PDF

Early growth response-1, a dynamic conduit in cardiovascular disease.

Front Cardiovasc Med

November 2024

Vascular Biology and Translational Research, Department of Pathology, Faculty of Medicine and Health, School of Biomedical Sciences, University of New South Wales, Sydney, NSW, Australia.

The transcription factor, early growth response-1 (Egr-1) is the product of a prototypic immediate-early gene that plays an integral role in the pathogenesis of multiple cardiovascular diseases. Egr-1 has been linked with atherogenesis, myocardial ischemia-reperfusion injury, cardiac fibrosis and heart failure. Egr-1 expression is triggered by a host of factors including cytokines, hormones, growth factors, hyperglycaemia, biomechanical forces and oxygen deprivation.

View Article and Find Full Text PDF

Antisense oligodeoxynucleotides can bind to target RNAs and cleave them using RNase H. Despite the high activity of antisense oligodeoxynucleotides modified with locked nucleic acids (LNA) at several bases at both the 5' and 3' ends (LNA gapmer), toxicity has been reported, necessitating additional backbone modifications to reduce toxicity. In this study, we introduced a sulfonamide linkage into the LNA gapmer to elucidate its fundamental properties such as hybridization, base recognition, and induction of RNase H activity.

View Article and Find Full Text PDF

CsCBF2 contributes to cold repression of chlorophyll and carotenoid biosynthesis in albino Camellia sinensis cv. Baiye 1.

Tree Physiol

December 2024

Anhui Agricultural Universtiy, No. 130 of Changjiang West Road, Hefei, 230036, Anhui, China.

C-repeat binding factors (CsCBFs) play a pivotal role in regulating cold response in higher plants. Camellia sinensis cv. Baiye 1, a representative albino tea cultivar, has been identified as temperature-sensitive based on long-term observations by tea farmers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!